Sarepta Therapeutics, Inc.

Q4 2025 13F Holdings Report, Stock Holdings

Signature - Title
Ryan Wong - Executive Vice President, Chief Financial Officer
Location
Cambridge, MA
Holdings as of
31 Dec 2025
Value $
$0
Num holdings
0
Filing time
12 Feb 2026, 20:57:42 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included .
SEC
View on sec.gov

Sarepta Therapeutics, Inc. didn't report any stock holdings as of Q4 2025. Check options holdings.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Ryan Wong Executive Vice President, Chief Financial Officer Las Vegas, Nevada 12 Feb 2026